Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

alpha pharmaceuticals limited - cimetidine 400mg (weight adjusted on basis of coa) - tablet - 400 mg - active: cimetidine 400mg (weight adjusted on basis of coa) excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium stearate maize starch povidone powdered cellulose purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets usp are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indic

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for healing of les

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

avkare, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

alpha pharmaceuticals limited - cimetidine 200mg (weight adjusted on basis of coa) - tablet - 200 mg - active: cimetidine 200mg (weight adjusted on basis of coa) excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium stearate maize starch povidone powdered cellulose purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

alpha pharmaceuticals limited - cimetidine 800mg (weight adjusted on basis of coa) - tablet - 800 mg - active: cimetidine 800mg (weight adjusted on basis of coa) excipient: colloidal silicon dioxide hypromellose macrogol 6000 magnesium stearate maize starch povidone powdered cellulose purified talc purified water sodium laurilsulfate sodium starch glycolate titanium dioxide

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

blenheim pharmacal, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg - cimetidine tablets are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

proficient rx lp - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: cimetidine is contraindicated for patients known to have hypersensitivity to the product.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets usp are indicated in: cimetidine is contraindicated for patients known to have hypersensitivity to the product.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dispensing solutions, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: 1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. 2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. 3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than eight weeks. 4) erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for twelve weeks for healin